Is a complete NSE/ZENITHDRUG research report available?

No complete published report is available for nse/ZENITHDRUG (NSE/ZENITHDRUG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/ZENITHDRUG stock profile: metrics, valuation and analysis

Market cap	837.7M
Revenue (ttm)	1.7B
Net income (ttm)	39.4M
EPS (ttm)	₹2.30
Shares out	17.1M
P/E (trailing)	21.2x
Volume	57,600
Beta	1.40

All NSE/ZENITHDRUG indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

INR

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	182
Employees Change	56%
Employees Change Percent	44.44
Enterprise value	INR 1.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Industry PE	27.23
Isin	INE0QWN01013
Last refreshed	2026-09-09
Market cap	INR 837.7M
Price	INR 48.85
Price currency	INR
Sector	Healthcare
Sector PE	48.19
Sector PE Fwd	38.62
Sic	2834
Symbol	nse/ZENITHDRUG
Website	https://zenithdrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.71%
EV Earnings	35.16x
EV/EBIT	22.68x
EV/EBITDA	11.4x
EV/Sales	0.81x
FCF yield	-1%
P/B ratio	1.12x
P/E ratio	21.24x
P/S ratio	0.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.57%
EBITDA Margin	7.1%
Gross margin	28.42%
Gross Profit	INR 486.7M
Gross Profit Growth	6.54%
Gross Profit Growth Q	18.15%
Gross Profit Growth3 Y	33%
Net Income	INR 39.4M
Net Income Growth	-44.94%
Net Income Growth Q	-71.9%
Net Income Growth Qo Q	-31.19%
Net Income Growth3 Y	5.06%
Pretax Margin	3.15%
Profit Margin	2.3%
ROA	2.19
Roa5y	5.68
ROCE	6.43
ROE	5.46
Roe5y	20.52
ROIC	3.45
Roic5y	13.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-30.18%
EPS Growth	-44.92
EPS Growth Q	184.6
EPS Growth Qo Q	-30.94
EPS Growth3 Y	-6.71
OCF Growth3 Y	36.64%
Revenue Growth	28.43x
Revenue Growth Qo Q	18.89x
Revenue Growth3 Y	29.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.98
Assets	INR 1.9B
Cash	INR 2.6M
Current Assets	INR 1.3B
Current Liabilities	INR 924.8M
Debt	INR 551.1M
Debt EBITDA	INR 4.53
Debt Equity	INR 0.74
Debt FCF	INR -65.55
Equity	INR 749.3M
Interest Coverage	1.09
Liabilities	INR 1.1B
Long Term Assets	INR 585.6M
Long Term Liabilities	INR 201.1M
Net Cash	INR -548.4M
Net Cash By Market Cap	INR -65.47
Net Debt EBITDA	INR 4.51
Net Debt Equity	INR 0.73
Tangible Book Value	INR 707.5M
Tangible Book Value Per Share	INR 41.35
WACC	10.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.99
Net Working Capital	INR 712.1M
Quick ratio	0.8
Working Capital	INR 364.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend per share	INR 0
Last Dividend	INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-30.16%
200-day SMA	46.34
50-day SMA	46.33
50-day SMA vs 200-day SMA	50under200
All Time High	154.4
All Time High Change	-68.36%
All Time High Date	2024-09-26
All Time Low	33.3
All Time Low Change	46.7%
All Time Low Date	2026-03-30
ATR	2.57
Beta	1.4
Beta1y	0.87
Beta2y	0.49
Ch YTD	-2.69
High	51
High52	73.45
High52 Date	2025-09-30
High52ch	-33.49%
Low	45.5
Low52	33.3
Low52 Date	2026-03-30
Low52ch	46.7%
Ma50ch	5.44%
Price vs 200-day SMA	5.41%
RSI	61.39
RSI Monthly	43.54
RSI Weekly	52.56
Sharpe ratio	-0.39x
Sortino ratio	-0.48
Total Return	0.04%
Tr YTD	-2.69
Tr1m	16.31%
Tr1w	18%
Tr3m	20.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,148,800%
Net Borrowing	48,348,000
Shares Insiders	69.98%
Shares Out	17,148,800
Shares Qo Q	-0.36%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	9,800x
Bv Per Share	43.79
CAPEX	INR -97.1M
Ch1m	16.31
Ch1w	18
Ch1y	-30.16
Ch3m	20.32
Ch6m	8.08
Change	7.48%
Change From Open	6.2
Close	45.45
Days Gap	1.21
Depreciation Amortization	60,480,000
Dollar Volume	2,813,760
Earnings Date	2026-08-28
EBIT	INR 61.1M
EBITDA	INR 121.6M
EPS	INR 2.3
F Score	5
FCF	INR -8.4M
FCF EV Yield	-0.61x
FCF Per Share	INR -0.49
Financing CF	48,349,000
Fiscal Year End	March
Founded	1,956
Graham Number	47.60335
Graham Upside	-2.55
Income Tax	INR 14.4M
Investing CF	-137,054,000
Is Primary Listing	1
Last Earnings Date	2026-05-29
Last Report Date	2026-03-31
Lynch Fair Value	INR 11.64
Lynch Upside	-76.17
Ma150	44.53
Ma150ch	9.71%
Ma20	42.9
Ma20ch	13.87%
Net CF	-19,000
Open	46
P OCF Ratio	9.45
Position In Range	60.91
Ppne	468,795,000
Price Date	2026-09-08
Price EBITDA	INR 6.89
Ptbv Ratio	1.18
Relative Volume	4.77x
Revenue	1,712,198,000x
Tax By Revenue	0.84x
Tax Rate	26.82%
Tr6m	8.08%
Volume	57,600

NSE/ZENITHDRUG (NSE/ZENITHDRUG)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ZENITHDRUG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ZENITHDRUG indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/ZENITHDRUG

Frequently asked questions